阿尔茨海默病的诊断模型基于与PANoptosis相关的基因
Erdong Zhang1,2, Fengqiu Dai3
1State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, China.
Journal of Alzheimer's disease : JAD
|December 31, 2023
概括
这项研究确定了阿尔茨海默病 (AD) 患者的三个PANoptosis模式,开发了一个PANscore,用于个性化的AD风险评估和治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 阿尔茨海默氏病 (AD) 的病理生理学涉及到热,光和死.
- 在AD中,研究了一种新的促炎性编程细胞死亡途径PANOPTOSIS.
研究的目的:
- 为了研究PANoptosis在阿尔茨海默病患者中的作用.
- 开发基于PANoptosis模式的AD风险分层系统.
主要方法:
- 共识聚类和WGCNA确定了PANoptosis的关键基因.
- 开发了 LASSO-Cox 回归和 PANscore 系统.
- 在AD转基因小鼠中通过qRT-PCR验证了PANoptosis中心基因表达.
主要成果:
- 在AD患者中发现了三种不同的PANoptosis模式,具有独特的分子/临床特征.
- 创建了一个风险评分系统,PANscore,用于个人患者分析.
- 在高PANscore/AD患者中观察到较低的毛囊辅助T (Tfh) 细胞水平,与GSDMD和MLKL负相关.
结论:
- 这些发现使得AD治疗的个性化患者分层成为可能.
- 这项研究推进了针对阿尔茨海默病的精准医学方法.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


